Physician profile
Bufford Moore
NPI 1881697183
$4,528.17
in general payments reported to CMS, 2019-2025
43 companies · $1,052 in 2025
The $1,052 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $126 · 2021: $166 · 2022: $85.17 · 2023: $1,243 · 2024: $1,615 · 2025: $1,052.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,909.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $747.10 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $641.39 | 2023-2025 | Caplyta |
| Lilly USA, LLC | $445.98 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $217.76 | 2023-2025 | Veozah |
| Glaxosmithkline, LLC. | $211.11 | 2023-2025 | Arexvy, Trelegy Ellipta |
| Smith+Nephew, INC. | $175.38 | 2019-2021 | |
| Novo Nordisk INC | $158.01 | 2024-2025 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $150.76 | 2024-2025 | |
| Aimmune Therapeutics, INC. | $140.68 | 2024-2025 | Zenpep |
| Nestle Healthcare Nutrition INC. | $140.08 | 2023 | |
| Abbvie INC. | $138.01 | 2023-2025 | |
| Pfizer INC. | $129.95 | 2023-2024 | |
| Otsuka America Pharmaceutical, INC. | $106.58 | 2023-2024 | Rexulti, Nuedexta, Abilify Maintena |
| Exact Sciences Corporation | $93.35 | 2023-2025 | Cologuard Collection Kit |
| Tela Bio, INC. | $89.88 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bufford Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.